|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Marc DamelinPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG Edition: Softcover Reprint of the Original 1st 2018 ed. Dimensions: Width: 15.50cm , Height: 1.90cm , Length: 23.50cm Weight: 0.563kg ISBN: 9783030086275ISBN 10: 3030086275 Pages: 357 Publication Date: 08 February 2019 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationMarc Damelin is Senior Director, Biology at Mersana Therapeutics in Cambridge, Massachusetts. His group is responsible for the discovery of therapeutic ADCs enabled by Mersana's proprietary linker-payload-scaffold technologies. Prior, Marc spent 10 years at Pfizer Inc. in the Oncology Research Unit, where he led ADC discovery teams and ultimately oversaw the ADC portfolio. He received his Ph.D. in Biophysics from Harvard University and conducted postdoctoral research at Columbia University Medical School as a Fellow of the Damon Runyon Cancer Research Foundation. Tab Content 6Author Website:Countries AvailableAll regions |